All subjects were started on GLP-1 analog monotherapy, and 22.9% were initiated on the add-on treatment (bupropion/naltrexone)
Many municipalities offer mail-back programs through the DEA if in-person drop-off is unavailable
Yes, both Wegovy (semaglutide) and Zepbound (tirzepatide) are FDA-approved for weight management in eligible patients
Before starting Hepaglide 2.4mg Injection (1 Multi-dose Disposable Pen, 4 Needle, 4 Alcohol Swab), inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems
Gecele M, Francesetti G, Meluzzi A
Yesterday we published a detailed article on the growing medical and strategic evidence for using GLP-1s to treat addiction